JUVA LIFE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0211 USD | -0.94% |
|
+12.23% | -0.47% |
| Apr. 10 | Juva Life Inc. Unveils New Cannabis Vape Category - Rosin Absolute | CI |
| 2023 | Juva Life Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 |
|---|---|---|---|
| Capitalization 1 | 128 | 29.65 | 10.4 |
| Enterprise Value (EV) 1 | 128 | 31.27 | 17.78 |
| P/E ratio | -7.74 x | -2.51 x | -0.99 x |
| Yield | - | - | - |
| Capitalization / Revenue | 132,342,381 x | 7,665,181 x | 1,804,127 x |
| EV / Revenue | 132,356,695 x | 8,085,207 x | 3,084,662 x |
| EV / EBITDA | -11,630,404 x | -3,144,340 x | -2,228,670 x |
| EV / FCF | -13,506,702 x | -2,656,689 x | -1,995,336 x |
| FCF Yield | -0% | -0% | -0% |
| Price to Book | 19.5 x | 2.07 x | 1.07 x |
| Nbr of stocks (in thousands) | 131,621 | 164,016 | 164,016 |
| Reference price 2 | 0.9725 | 0.1808 | 0.0634 |
| Announcement Date | 4/29/21 | 4/29/22 | 4/27/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Net sales | - | - | 0.9672 | 3.868 | 5.764 |
| EBITDA | - | -6.488 | -11.01 | -9.945 | -7.978 |
| EBIT 1 | -2.967 | -6.501 | -11.07 | -10.17 | -8.941 |
| Operating Margin | - | - | -1,144.07% | -262.91% | -155.12% |
| Earnings before Tax (EBT) 1 | -6.739 | -8.981 | -16.18 | -11.31 | -10.4 |
| Net income 1 | -6.739 | -8.981 | -16.24 | -11.36 | -10.48 |
| Net margin | - | - | -1,678.67% | -293.68% | -181.87% |
| EPS 2 | -0.1306 | -0.1068 | -0.1256 | -0.0720 | -0.0639 |
| Free Cash Flow | - | 0.2128 | -9.478 | -11.77 | -8.91 |
| FCF margin | - | - | -979.93% | -304.33% | -154.59% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 4/22/20 | 4/22/20 | 4/29/21 | 4/29/22 | 4/27/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Net Debt 1 | - | 1.31 | 0.01 | 1.62 | 7.38 |
| Net Cash position 1 | 2.36 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -0.2019 x | -0.001258 x | -0.1633 x | -0.9252 x |
| Free Cash Flow | - | 0.21 | -9.48 | -11.8 | -8.91 |
| ROE (net income / shareholders' equity) | - | -3,246% | -534% | -108% | -87.1% |
| ROA (Net income/ Total Assets) | - | -83.6% | -62.3% | -35% | -27.2% |
| Assets 1 | - | 10.74 | 26.07 | 32.42 | 38.51 |
| Book Value Per Share 2 | 0.0200 | -0.0100 | 0.0500 | 0.0900 | 0.0600 |
| Cash Flow per Share 2 | 0.0500 | 0.0100 | 0.0200 | 0.0200 | 0 |
| Capex 1 | 0.45 | 1.87 | 8.28 | 2.06 | 5.33 |
| Capex / Sales | - | - | 856.01% | 53.23% | 92.43% |
| Announcement Date | 4/22/20 | 4/22/20 | 4/29/21 | 4/29/22 | 4/27/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -0.47% | 3.46M | |
| +23.05% | 3.66B | |
| +109.78% | 2B | |
| +87.30% | 61.69M |
- Stock Market
- Equities
- JUVAF Stock
- Financials Juva Life Inc.
